Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

Add To Watchlist

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Volume

View:

Post by DIYGuy on Jul 28, 2017 10:38am

Volume

The day before the consolidation announcement we were 25 cents. Since that time we have lost about half the value of COTI on the just under 800,000 shares traded. The adjusted float is just under 15MM. So, we have around 14MM that are hanging in because they believe or just can't get out with no volume on the bid price.

Would love to know how many shares Wayne Danter still has and how many he has sold. If he owns over a certain percentage I believe he has to disclose. Anyone have any info?

111